Stockreport

Pharvaris to Host Virtual Investor Event on October 23, 2024

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF ZUG, Switzerland, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor anta [Read more]